RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. D/E ratio (%)

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndD/E ratio (%) (Million USD)YoY (%)
Dec 31, 20247.6+198.91%
Dec 31, 20232.5-67.18%
Dec 31, 20227.7-28.94%
Dec 31, 202110.8-21.28%
Dec 31, 202013.8-15.86%
Dec 31, 201916.4+16.51%
Dec 31, 201814-8.80%
Dec 31, 201715.4-23.96%
Dec 31, 201620.2-9.46%
Dec 31, 201522.4-30.61%
Dec 31, 201432.2-21.35%
Dec 31, 201341-21.18%
Dec 31, 201252-9.20%
Dec 31, 201057.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)